Accessing extended data from asthma and COPD patients
The Extended Salford Lung Study ("Ex-SLS") Data Access Project
This study is trying to gather more information from asthma and COPD patients to better understand their health journey and how their conditions change over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | GlaxoSmithKline Industry-sponsored |
| Locations | 1 site (Manchester) |
| Trial ID | NCT03152669 on ClinicalTrials.gov |
What this trial studies
This project aims to broaden access to data from patients who participated in the Salford Lung Study, focusing on asthma and chronic obstructive pulmonary disease (COPD). By collecting additional subject-level data through electronic medical records and a patient questionnaire, researchers hope to gain insights into the entire disease journey of these patients over a period of up to 10 years. This observational study will enhance the understanding of disease risk, treatment, and progression in asthma and COPD patients.
Who should consider this trial
Good fit: Ideal candidates are individuals who participated in the original Salford Lung Study and can provide consent for additional data collection.
Not a fit: Patients who were lost to follow-up, withdrew consent, or are too ill to participate may not benefit from this study.
Why it matters
Potential benefit: If successful, this project could lead to improved treatment strategies and better management of asthma and COPD.
How similar studies have performed: Other studies have successfully utilized extensive patient data to improve understanding of chronic diseases, making this approach promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects who were randomized to treatment in the original SLS studies * Subjects who are able to, and choose to, provide written consent for the additional information to be collected. Exclusion Criteria: * Subjects who were lost to follow-up/moved away, withdrew consent or died during or subsequent to the original SLS studies. * Subjects considered (at the discretion of the investigator) as too ill to participate or without the mental capacity to provide informed consent.
Where this trial is running
Manchester
- GSK Investigational Site — Manchester, United Kingdom (Recruiting)
Study contacts
- Study coordinator: US GSK Clinical Trials Call Center
- Email: GSKClinicalSupportHD@gsk.com
- Phone: 877-379-3718
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.